Compagnie Lombard Odier SCmA’s AC Immune ACIU Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10,000	Closed	-$25.2K	–	467
2024 Q4	$27K	Hold	10,000	–	–	﹤0.01%	372
2024 Q3	$37.8K	Hold	10,000	–	–	﹤0.01%	359
2024 Q2	$39.9K	Hold	10,000	–	–	﹤0.01%	348
2024 Q1	$29.6K	Hold	10,000	–	–	﹤0.01%	386
2023 Q4	$50K	Hold	10,000	–	–	﹤0.01%	416
2023 Q3	$28.5K	Hold	10,000	–	–	﹤0.01%	469
2023 Q2	$29.6K	Hold	10,000	–	–	﹤0.01%	459
2023 Q1	$23.4K	Hold	10,000	–	–	﹤0.01%	509
2022 Q4	$20K	Hold	10,000	–	–	﹤0.01%	567
2022 Q3	$32K	Hold	10,000	–	–	﹤0.01%	501
2022 Q2	$36K	Hold	10,000	–	–	﹤0.01%	476
2022 Q1	$40K	Hold	10,000	–	–	﹤0.01%	473
2021 Q4	$49K	Sell	10,000 -2,000	-17%	-$11.6K	﹤0.01%	507
2021 Q3	$80K	Hold	12,000	–	–	﹤0.01%	455
2021 Q2	$96K	Sell	12,000 -213,359	-95%	-$1.47M	﹤0.01%	417
2021 Q1	$1.72M	Buy	225,359 +208,359	+1,226%	+$1.49M	0.04%	166
2020 Q4	$88K	Hold	17,000	–	–	﹤0.01%	393
2020 Q3	$83K	Sell	17,000 -3,000	-15%	-$21.5K	﹤0.01%	352
2020 Q2	$134K	Hold	20,000	–	–	﹤0.01%	303
2020 Q1	$138K	Sell	20,000 -4,000	-17%	-$31.3K	0.01%	272
2019 Q4	$204K	Sell	24,000 -11,539	-32%	-$76.9K	0.01%	250
2019 Q3	$176K	Hold	35,539	–	–	0.01%	255
2019 Q2	$197K	Hold	35,539	–	–	0.01%	248
2019 Q1	$180K	Buy	35,539 +10,700	+43%	+$68.1K	0.01%	298
2018 Q4	$236K	Sell	24,839 -8,700	-26%	-$82.1K	0.01%	255
2018 Q3	$268K	Buy	33,539 +30,039	+858%	+$302K	0.01%	257
2018 Q2	$33K	Hold	3,500	–	–	﹤0.01%	477
2018 Q1	$37K	Sell	3,500 -3,500	-50%	-$42.6K	﹤0.01%	477
2017 Q4	$90K	Buy	7,000 +3,500	+100%	+$41.2K	﹤0.01%	491
2017 Q3	$40K	Hold	3,500	–	–	﹤0.01%	551
2017 Q2	$31K	Buy	3,500 +1,500	+75%	+$13.9K	﹤0.01%	574
2017 Q1	$21K	Hold	2,000	–	–	﹤0.01%	630
2016 Q4	$26K	Hold	2,000	–	–	﹤0.01%	677
2016 Q3	$33K	Buy	+2,000	New	+$34.6K	﹤0.01%	737

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ACIU Position: Q1 2025 in Review

Compagnie Lombard Odier SCmA sold out of AC Immune (ACIU) in Q1 2025, closing a stake of 10,000 shares — an estimated $25.2K sold.

Compagnie Lombard Odier SCmA first reported a position in ACIU in Q3 2016 and held it in 34 quarters. The position peaked at $1.72M in Q1 2021. 41 funds tracked by Wall St. Rank hold ACIU as of Q1 2025.

Compagnie Lombard Odier SCmA reported no remaining AC Immune position as of Q1 2025 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 10,000 AC Immune shares in Q1 2025, an estimated $25.2K.
Compagnie Lombard Odier SCmA first reported a position in AC Immune in Q3 2016 and held it in 34 quarters.
Compagnie Lombard Odier SCmA's AC Immune position peaked at $1.72M in Q1 2021.
41 funds tracked by Wall St. Rank held AC Immune as of Q1 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2025, filed 16 Apr 2025.